Staging and restaging of advanced esophageal cancer

Current Opinion in Gastroenterology

Volumn 24, Issue 4, 2008, Pages 530-534

  Jamil, Laith H ^a   Gill, Kanwar Rupinder S ^a   Wallace, Michael B ^a,b  

^a MAYO CLINIC   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Esophageal cancer; Restaging; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADJUVANT THERAPY; ADVANCED CANCER; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC IMAGING; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS STRICTURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMAGE ANALYSIS; METHYLATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; REVIEW; TREATMENT RESPONSE;

BIOPSY, FINE-NEEDLE; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; HUMANS; LAPAROSCOPY; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS;

EID: 58349110306     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283025c91     Document Type: Review

References (40)

1. Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 2007; 84:365-373; discussion 374-375.
2. Wijnhoven BP, Tran KT, Esterman A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007; 245:717-725.
3. Pedrazzani C, deManzoni G, Marrelli D, et al. Nodal staging in adenocarcinoma of the gastro-esophageal junction: proposal of a specific staging system. Ann Surg Oncol 2007; 14:299-305.
4. Takeno S, Noguchi T, Takahashi Y, et al. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification. Ann Surg Oncol 2007; 14:1431-1438.
5. Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 2002; 74:1026-1032.
6. Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 2005; 7:422-430.
7. Mortensen MB, Edwin B, Hunerbein M, et al. Impact of endoscopic ultrasonography (EUS) on surgical decision-making in upper gastrointestinal tract cancer: an international multicenter study. Surg Endosc 2007; 21: 431-438.
8. van Vliet EP, Eijkemans MJ, Kuipers EJ, et al. Publication bias does not play a role in the reporting of the results of endoscopic ultrasound staging of upper gastrointestinal cancers. Endoscopy 2007; 39:325-332.
9. Shimpi RA, George J, Jowell P, Gress FG. Staging of esophageal cancer by EUS: staging accuracy revisited. Gastrointest Endosc 2007; 66:475-482.
10. Barbour AP, Rizk NP, Gerdes H, et al. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg 2007; 205:593-601.
11. Kutup A, Link BC, Schurr PG, et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy 2007; 39:715-719.
12. Noh KW, Wallace MB, Pascual JM, et al. Fine-needle aspiration of peritumoral lymph nodes in esophageal cancer with endobronchial ultrasound. Endoscopy 2006; 38:953.
13. Vazquez-Sequeiros E, Levy MJ, Clain JE, et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 2006; 63:204-211.
14. Vu C, Tsang S, Doig L, Meenan J. The preferred choice for radial endosono- graphic staging of esophageal cancer: standard echoendoscope or nonoptic esophagoprobe? Surg Endosc 2007; 21:1617-1622.
15. Wallace MB, Hawes RH, Sahai AV, et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000; 51:309-313.
16. Moorjani N, Junemann-Ramirez M, Judd O, et al. Endoscopic ultrasound in oesophageal carcinoma: comparison with multislice computed tomography and importance in the clinical decision making process. Minerva Chir 2007; 62:217-223.
17. Pfau PR, Perlman SB, Stanko P, et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positronemission tomography. Gastrointest Endosc 2007; 65:377-384. 18 Kaiser GM, Sotiropoulos GC, Fruhauf NR, et al. Value of staging laparoscopy for multimodal therapy planning in esophago-gastric cancer. Int Surg 2007; 92:128-132.
18. Kaushik N, Khalid A, Brody D, et al. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. Ann Thorac Surg 2007; 83:2000-2002.
19. Little SG, Rice TW, Bybel B, et al. Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg 2007; 31:791 -796.
20. Meyers BF, Downey RJ, Decker PA, et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 2007; 133:738-745.
21. Katsoulis IE, Wong WL, Mattheou AK, et al. Fluorine-1 8 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study. Int J Surg 2007; 5:399-403.
22. van Westreenen HL, Westerterp M, Sloof GW, et al. Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg 2007; 94:1515-1520.
23. Mamede M, El Fakhri G, Abreu-e-Lima P, et al. Preoperative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 2007; 21:553-562.
24. Riddell AM, Allum WH, Thompson JN, et al. The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. Eur Radiol 2007; 17:391 -399.
25. Hayano K, Okazumi S, Shuto K, et al. Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Oncol Rep 2007; 18:901 -908.
26. Konski AA, Cheng JD, Goldberg M, et al. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys 2007; 69:358-363.
27. Port JL, Lee PC, Korst RJ, et al. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 2007; 84:393-400; discussion 400.
28. Mamede M, Abreu ELP, Oliva MR, et al. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol 2007; 30:377-388.
29. Zuccaro G Jr, Rice TW, Goldblum J, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94:906-912.
30. Beseth BD, Bedford R, Isacoff WH, et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66:827-831.
31. Mesenas S, Vu C, McStay M, et al. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy. Dis Esophagus 2008; 21:37-42.
32. Rizk NP, Venkatraman E, Bains MS, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007; 25:507-512.
33. Isenberg G, Chak A, Canto MI, et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc 1998; 48:158-163.
34. Willis J, Cooper GS, Isenberg G, et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 2002; 55:655-661.
35. Ribeiro A, Franceschi D, Parra J, et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol 2006; 101:121 6-1221.
36. Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 2005; 23:4483-4489.
37. Kalha I, Kaw M, Fukami N, et al. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer 2004; 101:940-947.
38. Cerfolio RJ, Bryant AS, Ohja B, et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2005; 129:1232-1241.
39. Pellise M, Castells A, Gines A, et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin Cancer Res 2004; 10:4444-4449.
40. Levy MJ, Clain JE, Clayton A, et al. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA. Gastrointest Endosc 2007; 66:483-490.